Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study

Seymour Diamond, Marcelo E. Bigal, Stephen Silberstein, Elizabeth Loder, Michael Reed, Richard B. Lipton

Research output: Contribution to journalArticle

256 Citations (Scopus)

Abstract

Objective. - To describe the patterns of medical treatment for migraineurs in the United States. Background. - Over the past decade, many new treatments for migraine have become available and awareness of migraine has improved. However, there is little information about the patterns of medical treatment in the US society. Design/Methods. - A validated self-administered headache questionnaire was mailed to a random sample of 120,000 US households. Each household member with severe headaches was asked to complete the survey. The questionnaire assessed headache features, disability, and patterns of medical treatment. Subjects were classified according to their use of headache preventive medication, as current users, coincident users (using effective medications for other medical reasons), lapsed users (had used in the past but not at the time of the survey), or never users. Results. - In 162,576 participants, the prevalence of migraine was 17.1% in women and 5.6% in men. Only 56.2% of those with migraine had ever received a medical diagnosis. Ninety-eight percent of the migraineurs used acute treatment for their migraine attacks. Forty-nine percent (49%) usually used over-the-counters, 20% usually used prescription medications, and 29% used both. Only 12.4% of migraineurs indicated that they were taking a migraine preventive medication, but 17.2% were using medications with potential antimigraine effects for other medical reasons. Current or past use of preventive medication was more likely in women than men (odds ratio [OR] = 1.37, 95% confidence interval [CI] 1.27-1.48), increased with age and individuals with high MIDAS grade (Grade IV vs I, OR 2.35, 95% CI 2.09-2.64). Preventive medication use increased with awareness of migraine and with illness severity. Conclusions. - Migraine remains undertreated in the US population. Barriers to preventive treatment are greater in younger age groups, men, and people unaware that they have migraine.

Original languageEnglish (US)
Pages (from-to)355-363
Number of pages9
JournalHeadache
Volume47
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Migraine Disorders
Cross-Sectional Studies
Headache
Therapeutics
Odds Ratio
Confidence Intervals
Prescriptions
Age Groups
Surveys and Questionnaires
Population

Keywords

  • Migraine
  • Prevalence
  • Prevention
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Patterns of diagnosis and acute and preventive treatment for migraine in the United States : Results from the American migraine prevalence and prevention study. / Diamond, Seymour; Bigal, Marcelo E.; Silberstein, Stephen; Loder, Elizabeth; Reed, Michael; Lipton, Richard B.

In: Headache, Vol. 47, No. 3, 03.2007, p. 355-363.

Research output: Contribution to journalArticle

Diamond, Seymour ; Bigal, Marcelo E. ; Silberstein, Stephen ; Loder, Elizabeth ; Reed, Michael ; Lipton, Richard B. / Patterns of diagnosis and acute and preventive treatment for migraine in the United States : Results from the American migraine prevalence and prevention study. In: Headache. 2007 ; Vol. 47, No. 3. pp. 355-363.
@article{b055ff671e59481faa9f6871e31204bd,
title = "Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study",
abstract = "Objective. - To describe the patterns of medical treatment for migraineurs in the United States. Background. - Over the past decade, many new treatments for migraine have become available and awareness of migraine has improved. However, there is little information about the patterns of medical treatment in the US society. Design/Methods. - A validated self-administered headache questionnaire was mailed to a random sample of 120,000 US households. Each household member with severe headaches was asked to complete the survey. The questionnaire assessed headache features, disability, and patterns of medical treatment. Subjects were classified according to their use of headache preventive medication, as current users, coincident users (using effective medications for other medical reasons), lapsed users (had used in the past but not at the time of the survey), or never users. Results. - In 162,576 participants, the prevalence of migraine was 17.1{\%} in women and 5.6{\%} in men. Only 56.2{\%} of those with migraine had ever received a medical diagnosis. Ninety-eight percent of the migraineurs used acute treatment for their migraine attacks. Forty-nine percent (49{\%}) usually used over-the-counters, 20{\%} usually used prescription medications, and 29{\%} used both. Only 12.4{\%} of migraineurs indicated that they were taking a migraine preventive medication, but 17.2{\%} were using medications with potential antimigraine effects for other medical reasons. Current or past use of preventive medication was more likely in women than men (odds ratio [OR] = 1.37, 95{\%} confidence interval [CI] 1.27-1.48), increased with age and individuals with high MIDAS grade (Grade IV vs I, OR 2.35, 95{\%} CI 2.09-2.64). Preventive medication use increased with awareness of migraine and with illness severity. Conclusions. - Migraine remains undertreated in the US population. Barriers to preventive treatment are greater in younger age groups, men, and people unaware that they have migraine.",
keywords = "Migraine, Prevalence, Prevention, Treatment",
author = "Seymour Diamond and Bigal, {Marcelo E.} and Stephen Silberstein and Elizabeth Loder and Michael Reed and Lipton, {Richard B.}",
year = "2007",
month = "3",
doi = "10.1111/j.1526-4610.2006.00631.x",
language = "English (US)",
volume = "47",
pages = "355--363",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Patterns of diagnosis and acute and preventive treatment for migraine in the United States

T2 - Results from the American migraine prevalence and prevention study

AU - Diamond, Seymour

AU - Bigal, Marcelo E.

AU - Silberstein, Stephen

AU - Loder, Elizabeth

AU - Reed, Michael

AU - Lipton, Richard B.

PY - 2007/3

Y1 - 2007/3

N2 - Objective. - To describe the patterns of medical treatment for migraineurs in the United States. Background. - Over the past decade, many new treatments for migraine have become available and awareness of migraine has improved. However, there is little information about the patterns of medical treatment in the US society. Design/Methods. - A validated self-administered headache questionnaire was mailed to a random sample of 120,000 US households. Each household member with severe headaches was asked to complete the survey. The questionnaire assessed headache features, disability, and patterns of medical treatment. Subjects were classified according to their use of headache preventive medication, as current users, coincident users (using effective medications for other medical reasons), lapsed users (had used in the past but not at the time of the survey), or never users. Results. - In 162,576 participants, the prevalence of migraine was 17.1% in women and 5.6% in men. Only 56.2% of those with migraine had ever received a medical diagnosis. Ninety-eight percent of the migraineurs used acute treatment for their migraine attacks. Forty-nine percent (49%) usually used over-the-counters, 20% usually used prescription medications, and 29% used both. Only 12.4% of migraineurs indicated that they were taking a migraine preventive medication, but 17.2% were using medications with potential antimigraine effects for other medical reasons. Current or past use of preventive medication was more likely in women than men (odds ratio [OR] = 1.37, 95% confidence interval [CI] 1.27-1.48), increased with age and individuals with high MIDAS grade (Grade IV vs I, OR 2.35, 95% CI 2.09-2.64). Preventive medication use increased with awareness of migraine and with illness severity. Conclusions. - Migraine remains undertreated in the US population. Barriers to preventive treatment are greater in younger age groups, men, and people unaware that they have migraine.

AB - Objective. - To describe the patterns of medical treatment for migraineurs in the United States. Background. - Over the past decade, many new treatments for migraine have become available and awareness of migraine has improved. However, there is little information about the patterns of medical treatment in the US society. Design/Methods. - A validated self-administered headache questionnaire was mailed to a random sample of 120,000 US households. Each household member with severe headaches was asked to complete the survey. The questionnaire assessed headache features, disability, and patterns of medical treatment. Subjects were classified according to their use of headache preventive medication, as current users, coincident users (using effective medications for other medical reasons), lapsed users (had used in the past but not at the time of the survey), or never users. Results. - In 162,576 participants, the prevalence of migraine was 17.1% in women and 5.6% in men. Only 56.2% of those with migraine had ever received a medical diagnosis. Ninety-eight percent of the migraineurs used acute treatment for their migraine attacks. Forty-nine percent (49%) usually used over-the-counters, 20% usually used prescription medications, and 29% used both. Only 12.4% of migraineurs indicated that they were taking a migraine preventive medication, but 17.2% were using medications with potential antimigraine effects for other medical reasons. Current or past use of preventive medication was more likely in women than men (odds ratio [OR] = 1.37, 95% confidence interval [CI] 1.27-1.48), increased with age and individuals with high MIDAS grade (Grade IV vs I, OR 2.35, 95% CI 2.09-2.64). Preventive medication use increased with awareness of migraine and with illness severity. Conclusions. - Migraine remains undertreated in the US population. Barriers to preventive treatment are greater in younger age groups, men, and people unaware that they have migraine.

KW - Migraine

KW - Prevalence

KW - Prevention

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33947258407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947258407&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.2006.00631.x

DO - 10.1111/j.1526-4610.2006.00631.x

M3 - Article

C2 - 17371352

AN - SCOPUS:33947258407

VL - 47

SP - 355

EP - 363

JO - Headache

JF - Headache

SN - 0017-8748

IS - 3

ER -